| Free radicals, antioxidant defense systems, and schizophrenia JQ Wu, TR Kosten, XY Zhang Progress in Neuro-Psychopharmacology and Biological Psychiatry 46, 200-206, 2013 | 519 | 2013 |
| Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics XY Zhang, YL Tan, LY Cao, GY Wu, Q Xu, Y Shen, DF Zhou Schizophrenia research 81 (2-3), 291-300, 2006 | 338 | 2006 |
| Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology XY Zhang, DF Zhou, PY Zhang, GY Wu, LY Cao, YC Shen Schizophrenia research 57 (2-3), 247-258, 2002 | 277 | 2002 |
| Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics XY Zhang, DF Zhou, LY Cao, GY Wu, YC Shen Neuropsychopharmacology 30 (8), 1532-1538, 2005 | 272 | 2005 |
| Changes in serum interleukin-2,-6, and-8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia XY Zhang, DF Zhou, LY Cao, PY Zhang, GY Wu, YC Shen Journal of Clinical Psychiatry 65 (7), 940-947, 2004 | 259 | 2004 |
| Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics MH Xiu, L Hui, YF Dang, T De Hou, CX Zhang, YL Zheng, TR Kosten, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 (8), 1508-1512, 2009 | 218 | 2009 |
| The prevalence and risk factors of psychological disturbances of frontline medical staff in china under the COVID-19 epidemic: workload should be concerned Y Zhou, W Wang, Y Sun, W Qian, Z Liu, R Wang, L Qi, J Yang, X Song, ... Journal of affective disorders 277, 510-514, 2020 | 217 | 2020 |
| Identifying a clinical signature of suicidality among patients with mood disorders: A pilot study using a machine learning approach IC Passos, B Mwangi, B Cao, JE Hamilton, MJ Wu, XY Zhang, J Quevedo, ... J Affect Disord 193, 109-116, 2016 | 192 | 2016 |
| Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of … C Song, XY Zhang, M Manku Journal of Neuroscience 29 (1), 14-22, 2009 | 192 | 2009 |
| Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics YL Tan, DF Zhou, LY Cao, YZ Zou, XY Zhang Neuroscience letters 382 (1-2), 27-32, 2005 | 185 | 2005 |
| Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia XY Zhang, J Liang, DC Chen, MH Xiu, F De Yang, TA Kosten, TR Kosten Psychopharmacology 222, 277-284, 2012 | 179 | 2012 |
| Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes J Wang, B Wang, SC Yang, CX Zhang, YL Zheng, YL Li, N Wang, ... Psychopharmacology 207 (3), 375-380, 2009 | 174* | 2009 |
| Low BDNF is associated with cognitive deficits in patients with type 2 diabetes YF Zhen, J Zhang, XY Liu, H Fang, LB Tian, DH Zhou, TR Kosten, ... Psychopharmacology 227, 93-100, 2013 | 165 | 2013 |
| Psychological resilience as a protective factor for depression and anxiety among the public during the outbreak of COVID-19 S Song, X Yang, H Yang, P Zhou, H Ma, C Teng, H Chen, H Ou, J Li, ... Frontiers in psychology 11, 618509, 2021 | 159 | 2021 |
| Prevalence, risk factors and clinical correlates of depression in quarantined population during the COVID-19 outbreak M Peng, B Mo, Y Liu, M Xu, X Song, L Liu, Y Fang, T Guo, J Ye, Z Yu, ... Journal of affective disorders 275, 119-124, 2020 | 157 | 2020 |
| Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial WF Zhang, YL Tan, XY Zhang, RCK Chan, HR Wu, DF Zhou The Journal of clinical psychiatry 71 (5), 7051, 2010 | 156 | 2010 |
| Gender differences in cognitive function of patients with chronic schizophrenia M Han, XF Huang, MH Xiu, L Hui, H Liu, TR Kosten, XY Zhang Progress in neuro-psychopharmacology and biological psychiatry 39 (2), 358-363, 2012 | 155 | 2012 |
| A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia XY Zhang, DF Zhou, PY Zhang, GY Wu, JM Su, LY Cao Journal of Clinical Psychiatry 62 (11), 878-883, 2001 | 154 | 2001 |
| Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity B Cao, RY Cho, D Chen, M Xiu, L Wang, JC Soares, XY Zhang Molecular psychiatry 25 (4), 906-913, 2020 | 144 | 2020 |
| Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients XY Zhang, MH Xiu, F De Yang, CN Haile, TA Kosten, TR Kosten The Journal of clinical psychiatry 73 (7), 7657, 2012 | 139 | 2012 |